Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 2Osteoporosis 1Neoplasms 1Myocardial Ischemia 1Hepatitis C, Chronic 1Heart Diseases 1Fibrosis 1Coronary Disease 1Colonic Neoplasms 1Clinical Stage III Esophageal Adenocarcinoma AJCC v8 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Cachexia 1Bone Diseases 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Cholecalciferol 4Calcium Carbonate 4Alendronate 4Letrozole 3Denosumab 3Calcium 3Absorptiometry, Photon 3Calcium Gluconate 2Toremifene 1Spectrum Analysis 1Radiotherapy 1Progestins 1Ibandronic Acid 1Hormone Replacement Therapy 1Goserelin 1Gonadotropin-Releasing Hormone 1Geritol 1Estrogens 1Estrogen Replacement Therapy 1Estrogen Antagonists 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium Citrate 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Osteoporosis × Dietary Supplements × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡